Consumer Credit Growth Accelerates in December Signaling Robust Spending Quantum Computing Stocks Surge on 2 Billion US Government Funding Plan Wall Street AI Rally Continues as Crypto Sentiment Plunges to Extreme Fear Infleqtion Stock Climbs 31 After Securing Government Backing Selling a Family Business for 32 Million Could Trigger a 740000 Tax Bill Without Proactive Planning SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Development IBM Q1 2026 Earnings Earnings Beat on Strong EPS Performance Stock Edges Higher UCL Q1 2026 Earnings EPS Beat Highlights Operational Efficiency Amid Revenue Discrepancy MSN Q1 2024 Earnings Narrowing Losses Amid Limited Revenue Disclosure Stock Surges 2026 HURN Q1 2026 Earnings EPS Beats Estimates as Consulting Services Maintain Momentum Orthofix Medical Inc OFIX Q1 2026 Earnings Significant EPS Beat Drives Stock Rally SEED Q4 2011 Earnings Stunning EPS Beat Drives Positive Momentum Cerus Corporation CERS Consolidates Near 273 as Support and Resistance Levels Hold MLACR Holds Steady at 023 With Minimal Price Movement Better Home Finance BETR Rallies 23 as Investors Eye Key Resistance at 2689 Lithium Americas Corp LAC Rises 246 as It Approaches Key Resistance Near 524 NervGen Pharma NGEN Dips 282 to 207 Approaching Key Support Insurance Tech Corgi Triples Valuation to 26B in Three Weeks with 106M Funding Round Lineage Cell Therapeutics Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Continues Pipeline Investment Ranger Energy Services RNGR Plunges 486 Tests Key Support at 1469 SLDP Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment Nutrien Ltd NTR Q1 2026 Earnings EPS Misses Estimates by 473 Amid Challenging Market Conditions GPC Q1 2026 Earnings Modest EPS Miss Amid Stable Operations ONCY Q3 2025 Earnings WiderthanExpected Loss Amid Clinical Progress HLX Q1 2026 Earnings Narrow Loss Wider Than Expected Stock Slides FGBIP Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Remains Stable COCP Q1 2026 Earnings WiderThanExpected Loss Weighs on EarlyStage Biotech